0000014272-14-000002.txt : 20140102
0000014272-14-000002.hdr.sgml : 20140101
20140102160641
ACCESSION NUMBER: 0000014272-14-000002
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20140101
FILED AS OF DATE: 20140102
DATE AS OF CHANGE: 20140102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lynch Thomas J. Jr.
CENTRAL INDEX KEY: 0001474056
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 14501867
MAIL ADDRESS:
STREET 1: 800 HOWARD AVENUE
STREET 2: YALE PHYSICIANS BUILDING, 2ND FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06519
3
1
wf-form3_138869678967110.xml
FORM 3
X0206
3
2014-01-01
1
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001474056
Lynch Thomas J. Jr.
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
1
0
0
0
Exhibit 24 - Thomas J. Lynch, Jr., M.D.
/s/ Katherine R. Kelly, attorney-in-fact for Thomas J. Lynch, Jr. M.D.
2014-01-02
EX-24
2
poa.txt
EXHIBIT 24 - THOMAS J. LYNCH, JR., M.D.
Exhibit 24
POWER OF ATTORNEY
I, Thomas J. Lynch, Jr., M.D., Director of Bristol-Myers Squibb
Company (the "Company"), a corporation duly organized and existing under
the laws of the State of Delaware, in the United States of America, and
having its principal place of business at 345 Park Avenue, New York,
New York, do hereby constitute and appoint each of Sandra Leung,
Katherine R. Kelly, and Robert J. Wollin, individually, as my lawful
attorney-in-fact and in my name, place and stead to execute and deliver
any and all documents relating to insider reporting requirements under
Section 16 of the Securities Exchange Act of 1934, with respect to
securities issued by the Company, including, without limitation, the
execution and filing of all Forms 3, 4 and 5, and to take such other action,
as such attorney considers necessary or appropriate, to effectuate such
transactions. This Power of Attorney shall remain in full force and effect
until I am no longer required to file Forms 3, 4, and 5 with respect to
securities issued by the Company, unless earlier revoked.
IN WITNESS WHEREOF, I have executed this Power of Attorney on this
18th day of December, 2013.
/s/ Thomas J. Lynch, Jr., M.D.
Thomas J. Lynch, Jr., M.D.